July 29, 2024 by Wiley Credit: Pixabay/CC0 Public DomainPast studies have suggested that taking cholesterol-lowering statin drugs may lower individuals’ risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one type was linked to lower risks of liver cancer. The findings are published by Wiley online in Cancer. Cholesterol absorption inhibitors,...
Category: <span>Pharmaceutical Updates</span>
One man’s mission to revive a forgotten, life-saving cancer drug
Dutch immunologist Jacques Neefjes believes the drug aclarubicin, unavailable in Europe for 20 years, could have helped 100,000 people with a rare blood cancer Eva AmsenSat 27 Jul 2024 12.00 EDT For the past decade, the Dutch immunologist Jacques (Sjaak) Neefjes has been on a mission to bring back a cancer drug that hasn’t been...
Chinese medicinal fungus shows promise in treating idiopathic pulmonary fibrosis
July 26, 2024 by Sichuan International Medical Exchange and Promotion Association Cordyceps sinensis (CS) improved mitochondrial dysfunction in bleomycin-induced BEAS-2B cells. (A) Representative transmission electron microscopy (TEM) images of BEAS-2B cells in the control, model, and CS groups. Credit: MedComm – Future Medicine (2024). DOI: 10.1002/mef2.91A study from China has reported that Cordyceps sinensis (CS),...
Experimental drug shows promise in clearing HIV from brain
July 26, 2024 by Tulane University Phosphorylation activation of CSF1R is increased with simian immunodeficiency virus. Credit: Brain (2024). DOI: 10.1093/brain/awae153An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study. For the first time, researchers at Tulane National Primate Research...
New shingles vaccine could reduce risk of dementia
July 25, 2024 by University of Oxford Credit: CC0 Public DomainA study of more than 200,000 people by researchers at the University of Oxford found at least a 17% reduction in dementia diagnoses in the six years after the new recombinant shingles vaccination, equating to 164 or more additional days lived without dementia. The paper...
Study finds biosimilars offer improved outcome and lower cost for rheumatoid arthritis treatment
July 25, 2024 by The University of Hong Kong Global price of biosimilar infliximab in July 2022. Credit: JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.18800A research team from the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) performed a cost-effectiveness analysis of treatment strategies for patients in Hong Kong with rheumatoid arthritis. The...
Antisense oligonucleotide treatment shows promise in treating Parkinson’s disease progression
NEWS RELEASE 25-JUL-2024 Peer-Reviewed PublicationTOKYO MEDICAL AND DENTAL UNIVERSITY IMAGE: RESEARCHERS FROM JAPAN INVESTIGATED HOW ASOS ADMINISTERED LOCALLY INTO THE BRAINS OF MICE MODELS FOR PARKINSON’S DISEASE CAN HELP PREVENT THE FORMATION AND SPREAD OF HARMFUL ASYN AGGREGATES THROUGH DIFFERENT REGIONS. THEIR FINDINGS SHOW ASOS COULD BE A PROMOTING THERAPEUTIC STRATEGY TO BOTH PREVENT AND...
Research helps show which type 2 diabetes medication may work best
JULY 23, 2024 by Tayler Shaw, CU Anschutz Medical Campus Credit: Unsplash/CC0 Public DomainAfter publishing research in 2022 that compared the effectiveness of four common medications for type 2 diabetes, University of Colorado Department of Medicine faculty member Neda Rasouli, MD, and a national team of researchers decided to delve deeper into their data to...
Botox could make walking easier in children with cerebral palsy
JULY 24, 2024 by Wiley Credit: Unsplash/CC0 Public DomainA randomized clinical trial published in Developmental Medicine & Child Neurology has assessed whether injections of botulinumtoxin-A in calf muscles benefit children with cerebral palsy. “We hypothesized that injections with botulinumtoxin-A in the calf muscles would make walking easier, caused by improved ankle joint functioning following spasticity...
Long-term sulfonylurea use tied to impaired awareness of hypoglycemia
JULY 24, 2024 by Lori Solomon The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the Annals of Family Medicine. Hsiang-Ju Cheng, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues investigated the relationship between...